Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland
Tiina Suominen(Tampere University), Bjarne Udd(Folkhälsans Forskningscentrum), Linda L. Bachinski(Baylor College of Medicine), Ralf Krahe(University of Helsinki), Leena Peltonen(University of Helsinki), Keith Baggerly(The University of Texas MD Anderson Cancer Center), Peter Hackman(Folkhälsans Forskningscentrum), S. Auvinen(Central Finland Health Care District), C. Angelini(University of Pisa)
Cited by 135
Related Papers
Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy
|New England Journal of Medicine|1998|759
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
|Cancer Cell|2018|705
MELAS: Clinical features, biochemistry, and molecular genetics
|Annals of Neurology|1992|508
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484